JJ

Jose Joseph

Active Director Director DIN 02674471
DIN 02674471 First appointment Jul 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2009
Shareholding value •••• Premium profile

About Jose Joseph

Data last updated:

Jose Joseph is a Director at Lycus Pharma Private Limited (since 2009). The company operates in Pharma. Lycus Pharma Private Limited reported revenue of ₹3.00 Cr (FY 2022).

DIN 02674471
Primary Designation Director
Industry Pharma
First Appointment 06 Jul 2009
Oldest Company Age 17 yrs
Largest company Lycus Pharma Private Limited · ₹3.00 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lycus Pharma Private Limited U52311KL2009PTC024412
Director06 Jul 20092009₹3.00 Cr (FY 2022)Active

Board colleagues of Jose Joseph

Directorship timeline

Open interactive timeline →
Lycus Pharma Private Limited
Premium access

Shareholding and investment profile for Jose Joseph

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jose Joseph

Jose Joseph currently holds 1 directorship: Lycus Pharma Private Limited (Director, since 06 Jul 2009, revenue ₹3.00 Cr (FY 2022)).

Jose Joseph was first appointed on 06 Jul 2009 as Director at Lycus Pharma Private Limited.

The current boards of Jose Joseph's companies include Jacob Job (Lycus Pharma Private Limited), Jayan Padmanabhan (Lycus Pharma Private Limited), Lathish Pulickaparambil Narayanan Nair (Lycus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available